David Thomson
2014 - MannKind
In 2014, David Thomson earned a total compensation of $1M as Corporate Vice President, General Counsel and Secretary at MannKind, a 77% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $294,591 |
|---|---|
| Option Awards | $202,195 |
| Salary | $409,154 |
| Stock Awards | $68,773 |
| Other | $33,065 |
| Total | $1,007,778 |
Thomson received $409.2K in salary, accounting for 41% of the total pay in 2014.
Thomson also received $294.6K in non-equity incentive plan, $202.2K in option awards, $68.8K in stock awards and $33.1K in other compensation.
Rankings
In 2014, David Thomson's compensation ranked 7,579th out of 13,032 executives tracked by ExecPay. In other words, Thomson earned more than 41.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,579 out of 13,032 | 42nd |
Division Manufacturing | 2,801 out of 4,965 | 44th |
Major group Chemicals And Allied Products | 950 out of 1,690 | 44th |
Industry group Drugs | 747 out of 1,369 | 45th |
Industry Pharmaceutical Preparations | 578 out of 1,042 | 45th |
Source: SEC filing on April 7, 2017.
Thomson's colleagues
We found four more compensation records of executives who worked with David Thomson at MannKind in 2014.
News
PRECISION BIOSCIENCES CEO Matthew Kane's 2020 pay slips 15% to $1.8M
April 12, 2021
MannKind CEO Michael PharmD's 2019 pay rises 3% to $1.6M
April 10, 2020
PRECISION BIOSCIENCES Chief Medical Officer Christopher Heery receives $2.2M in 2019
March 27, 2020
MannKind CEO Michael Castagna's 2018 pay rises 13% to $1.5M
March 28, 2019